查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489228

全球灌装药品合约製造市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Fill-finish Pharmaceutical Contract Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 168 Pages | 商品交期: 最快1-2个工作天内

价格

全球灌装药品合约製造市场的需求预计将从 2023 年的 83.6 亿美元达到 2032 年近 155.1 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.11%。

灌装完成製药合约製造涉及生产药品的最后步骤，其中将散装原料药填充到容器（西林瓶、注射器、安瓿）中，然后密封。过程包括灭菌、填充、封盖、贴标籤和包装，确保产品安全、无菌并可供分销。合约製造商向製药公司提供这些服务，帮助他们扩大生产规模、满足监管标准并缩短上市时间。这项服务对于需要无菌处理的生物製品、疫苗和注射药物至关重要。

市场动态

生物製药产品（包括生物製品、疫苗和细胞疗法）的不断增长推动了对灌装药品合约製造的需求。製药业日益全球化以及对灵活製造解决方案的需求推动了对灌装-完成合约製造服务的需求。这些服务使製药公司能够在全球范围内获得製造能力和专业知识，从而降低供应链风险并加快产品开发时间。药品生产和包装的严格监管要求凸显了与符合现行良好生产规范 (cGMP) 和其他监管标准、经验丰富的灌装药品合约製造商合作的重要性。

此外，外包非核心製造活动和专注于核心能力的趋势不断增长，这激励製药公司聘请灌装完成CMO来满足其製造需求，优化资源分配和营运效率。然而，监管障碍和内部製造的竞争可能会在未来几年挑战灌装药品合约製造市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球灌装製药合约製造市场的每个细分市场进行了包容性评估。灌装製药合约製造业的成长和趋势为本研究提供了整体方法。

市场区隔

灌装完成药品合约製造市场报告的这一部分提供了国家和区域层面的细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 西林瓶（玻璃西林瓶、塑胶西林瓶）
  • 预充式註射器 (PFS)（玻璃 PFS、塑胶 PFS）
  • 墨水匣
  • 其他产品

按分子

  • 大分子
  • 小分子

按最终用途

  • 生物製药公司
  • 製药公司

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的灌装药品合约製造市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。填充完成药品合约製造市场的主要参与者包括 Boehringer Ingelheim International GmbH、Catalent Inc.、Eurofins Scientific、Fresenius Kabi Contract Manufacturing、MabPlex International Co. Ltd.、Novartis AG、Recipharm AB、Societal CDMO、Simtra BioPharma Solutions（百特国际公司）、共生製药服务公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：灌装-成品製药合约製造 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 分子市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球灌装-成品製药合约製造市场分析：依产品

  • 概述（按产品）
  • 历史和预测数据
  • 按产品分析
  • 西林瓶（玻璃西林瓶、塑胶西林瓶）
  • 预充式註射器 (PFS)（玻璃 PFS、塑胶 PFS）
  • 墨水匣
  • 其他产品

第 6 章：全球灌装-成品製药合约製造市场分析：按分子

  • 分子概述
  • 历史和预测数据
  • 分子分析
  • 大分子
  • 小分子

第 7 章：全球灌装-成品製药合约製造市场分析：依最终用途

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 生物製药公司
  • 製药公司

第 8 章：全球灌装-成品製药合约製造市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：灌装製药合约製造公司的竞争格局

  • 灌装完成药品合约製造市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Boehringer Ingelheim International GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Catalent Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Eurofins Scientific
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Fresenius Kabi Contract Manufacturing
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MabPlex International Co. Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Novartis AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Recipharm AB
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Societal CDMO
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Simtra BioPharma Solutions (Baxter International Inc.)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Symbiosis Pharmaceutical Services
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114625

The global demand for Fill-finish Pharmaceutical Contract Manufacturing Market is presumed to reach the market size of nearly USD 15.51 Billion by 2032 from USD 8.36 Billion in 2023 with a CAGR of 7.11% under the study period 2024-2032.

Fill-finish pharmaceutical contract manufacturing involves the final steps in producing pharmaceutical products, where bulk drug substances are filled into containers (vials, syringes, ampoules) and then sealed. This process includes sterilization, filling, capping, labeling, and packaging, ensuring the product is safe, sterile, and ready for distribution. Contract manufacturers provide these services to pharmaceutical companies, helping them to scale production, meet regulatory standards, and reduce time-to-market. This service is crucial for biologics, vaccines, and injectable drugs requiring aseptic processing.

MARKET DYNAMICS

The growing pipeline of biopharmaceutical products, including biologics, vaccines, and cell therapies, drives the need for fill-finish pharmaceutical contract manufacturing. The increasing globalization of the pharmaceutical industry and the need for flexible manufacturing solutions drive the demand for fill-finish contract manufacturing services. These services enable pharmaceutical companies to access manufacturing capacity and expertise on a global scale, mitigating supply chain risks and accelerating product development timelines. The stringent regulatory requirements governing pharmaceutical manufacturing and packaging underscore the importance of partnering with experienced fill-finish pharmaceutical contract manufacturers that comply with current good manufacturing practices (cGMP) and other regulatory standards.

Furthermore, the growing trend towards outsourcing non-core manufacturing activities and focusing on core competencies incentivizes pharmaceutical companies to engage fill-finish CMOs for their manufacturing needs, optimizing resource allocation and operational efficiency. However, regulatory hurdles and competition from in-house manufacturing may challenge the fill-finish pharmaceutical contract manufacturing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fill-finish Pharmaceutical Contract Manufacturing. The growth and trends of Fill-finish Pharmaceutical Contract Manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fill-finish Pharmaceutical Contract Manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Vials (Glass Vials, Plastic Vials)
  • Prefilled Syringes (PFS) (Glass PFS, Plastic PFS)
  • Cartridges
  • Other Products

By Molecule

  • Large Molecules
  • Small Molecules

By End-Use

  • Biopharmaceutical Companies
  • Pharmaceutical Companies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fill-finish Pharmaceutical Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fill-finish Pharmaceutical Contract Manufacturing market include Boehringer Ingelheim International GmbH, Catalent Inc., Eurofins Scientific, Fresenius Kabi Contract Manufacturing, MabPlex International Co. Ltd., Novartis AG, Recipharm AB, Societal CDMO, Simtra BioPharma Solutions (Baxter International Inc.), Symbiosis Pharmaceutical Services. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Molecule
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Vials (Glass Vials, Plastic Vials) Historic and Forecast Sales By Regions
  • 5.5. Prefilled Syringes (PFS) (Glass PFS, Plastic PFS) Historic and Forecast Sales By Regions
  • 5.6. Cartridges Historic and Forecast Sales By Regions
  • 5.7. Other Products Historic and Forecast Sales By Regions

6. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY MOLECULE

  • 6.1. Overview By Molecule
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Molecule
  • 6.4. Large Molecules Historic and Forecast Sales By Regions
  • 6.5. Small Molecules Historic and Forecast Sales By Regions

7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-Use
  • 7.4. Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.5. Pharmaceutical Companies Historic and Forecast Sales By Regions

8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING COMPANIES

  • 9.1. Fill-finish Pharmaceutical Contract Manufacturing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Boehringer Ingelheim International GmbH
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Catalent Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Eurofins Scientific
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Fresenius Kabi Contract Manufacturing
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. MabPlex International Co. Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Novartis AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Recipharm AB
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Societal CDMO
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Simtra BioPharma Solutions (Baxter International Inc.)
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Symbiosis Pharmaceutical Services
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Vials (Glass Vials, Plastic Vials) Market Sales By Geography (USD MN)
  • Prefilled Syringes (PFS) (Glass PFS, Plastic PFS) Market Sales By Geography (USD MN)
  • Cartridges Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Analysis By Molecule (USD MN)
  • Large Molecules Market Sales By Geography (USD MN)
  • Small Molecules Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Global Fill-finish Pharmaceutical Contract Manufacturing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Fill-finish Pharmaceutical Contract Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Fill-finish Pharmaceutical Contract Manufacturing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Molecule
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Vials (Glass Vials, Plastic Vials) Market Sales By Geography (USD MN)
  • Prefilled Syringes (PFS) (Glass PFS, Plastic PFS) Market Sales By Geography (USD MN)
  • Cartridges Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Global Market Analysis By Molecule (USD MN)
  • Large Molecules Market Sales By Geography (USD MN)
  • Small Molecules Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.